Literature DB >> 30972571

Axenic amastigote cultivation and in vitro development of Leishmania orientalis.

Wetpisit Chanmol1, Narissara Jariyapan2, Pradya Somboon3, Michelle D Bates4, Paul A Bates4.   

Abstract

Leishmania (Mundinia) orientalis is a recently described new species that causes leishmaniasis in Thailand. To facilitate characterization of this new species, an in vitro culture system to generate L. orientalis axenic amastigotes was developed. In vitro culture conditions of the axenic culture-derived amastigotes were optimized by manipulation of temperature and pH. Four criteria were used to evaluate the resulting L. orientalis axenic amastigotes, i.e., morphology, zymographic analysis of nucleases, cyclic transformation, and infectivity to the human monocytic cell line (THP-1) cells. Results revealed that the best culture condition for L. orientalis axenic amastigotes was Grace's insect medium supplemented with FCS 20%, 2% human urine, 1% BME vitamins, and 25 μg/ml gentamicin sulfate, pH 5.5 at 35 °C. For promastigotes, the condition was M199 medium, 10% FCS supplemented with 2% human urine, 1% BME vitamins, and 25 μg/ml gentamicin sulfate, pH 6.8 at 26 °C. Morphological characterization revealed six main stages of the parasites including amastigotes, procyclic promastigotes, nectomonad promastigotes, leptomonad promastigotes, metacyclic promastigotes, and paramastigotes. Also, changes in morphology during the cycle were accompanied by changes in zymographic profiles of nucleases. The developmental cycle of L. orientalis in vitro was complete in 12 days using both culture systems. The infectivity to THP-1 macrophages and intracellular growth of the axenic amastigotes was similar to that of THP-1 derived intracellular amastigotes. These results confirmed the successful axenic cultivation of L. orientalis amastigotes. The axenic amastigotes and promastigotes can be used for further study on infection in permissive vectors and animals.

Entities:  

Keywords:  Axenic amastigote; Culture; Leishmania; Promastigote; Thailand; Zymography

Mesh:

Substances:

Year:  2019        PMID: 30972571     DOI: 10.1007/s00436-019-06311-z

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  6 in total

1.  In vitro efficacy of polymer coated miltefosine drug against leishmania tropica.

Authors:  Mehvish Khokhar; Muhammad Adnan Shereen; Momin Khan; Rahat Ullah Khan; Aamir Sohail; Imdad Ullah Khan; Inam Ullah Khan; Saadullah Khattak
Journal:  J Parasit Dis       Date:  2021-09-23

2.  Stimulation of metacyclogenesis in Leishmania (Mundinia) orientalis for mass production of metacyclic promastigotes.

Authors:  Wetpisit Chanmol; Narissara Jariyapan; Kanok Preativatanyou; Chonlada Mano; Pongsri Tippawangkosol; Pradya Somboon; Paul A Bates
Journal:  Front Cell Infect Microbiol       Date:  2022-09-05       Impact factor: 6.073

3.  Phlebotomine sand flies (Diptera: Psychodidae) and sand fly-borne pathogens in the Greater Mekong Subregion: a systematic review.

Authors:  John Hustedt; Didot Budi Prasetyo; Jodi M Fiorenzano; Michael E von Fricken; Jeffrey C Hertz
Journal:  Parasit Vectors       Date:  2022-10-05       Impact factor: 4.047

4.  LGAAP: Leishmaniinae Genome Assembly and Annotation Pipeline.

Authors:  Hatim Almutairi; Michael D Urbaniak; Michelle D Bates; Narissara Jariyapan; Godwin Kwakye-Nuako; Vanete Thomaz-Soccol; Waleed S Al-Salem; Rod J Dillon; Paul A Bates; Derek Gatherer
Journal:  Microbiol Resour Announc       Date:  2021-07-22

5.  In vitro anti-Leishmania activity of 8-hydroxyquinoline and its synergistic effect with amphotericin B deoxycholate against Leishmania martiniquensis.

Authors:  Wetpisit Chanmol; Padet Siriyasatien; Nuchpicha Intakhan
Journal:  PeerJ       Date:  2022-01-18       Impact factor: 2.984

6.  In Vitro Antileishmanial and Antischistosomal Activities of Anemonin Isolated from the Fresh Leaves of Ranunculus multifidus Forsk.

Authors:  Betelhem Sirak; Kaleab Asres; Asrat Hailu; Mthandazo Dube; Norbert Arnold; Cecile Häberli; Jennifer Keiser; Peter Imming
Journal:  Molecules       Date:  2021-12-10       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.